Posted in Big Business, Latest Brief: Merck is buying drug maker VelosBio for $2.75 billion in cash Merck (MRK) – Merck is buying privately held drugmaker VelosBio for $2.75 billion in cash, in a move designed to boost its oncology treatment pipeline. Sharing is caring!FacebookLinkedInTwitterTelegramWhatsAppSkype Related Related Articles This is why you might not get your prepaid meter any time soon Quebec to ban sale of new gasoline-powered cars from 2035 Apple’s Latest Macs Could Start a New Chip War Electrified by Tesla, Chinese startups are on the charge